STATIN-FIBRATE REPORT: Focus on Safety

There was no significant difference between the two groups for major coronary events and the study did not show any significant difference in progression to end-stage renal disease among non-dialysis patients (3). ... myalgia and rhabdomyolysis. Renal impairment may be a pre-disposing factor for rhabdomyolysis and the manufacturer of ... ................
................